These findings suggest that the unstable mitotic fidelity or dampen DNA damage response due to the inactivation of RB1, would expose tumor cells to novel vulnerability to agents that target these accumulated abnormalities to catastrophically trigger cell death, instead of resulting in CIN. The gene discussed is RB1; the disease is cervical squamous intraepithelial neoplasia.